20.09.2021 This scientific article represents a hypothetical elaboration about potential use of systemic disease-associated circulating rare cells in comprehension for in-depth cytological analysis at the single cellular level. We denote …
23.09.2021 We’ve been named one of @hello tomorrow’s Deep Tech Pioneers! Come and meet us at the “Hello Tomorrow Global Summit 2021” along with 3,500 disruptive startups, investors, corporations and …
01.09.2021 Cyto-hematological investigations conducted by our group using the Walderbach platform in various clinical research tasks has leveraged the discovery of circulating cellular markers to indicate bone marrow damage. Imbalances …
20.03.2020 As part of the immanent advancement of cell-based liquid biopsy, we are happy to announce the filing of the latest patent application of the SanoLibio Project introducing the discovery …
